Pronovost: Surveillance Bias Threatens Quality Payment Fairness
2. Costs and benefits of proposed measures should include rational prioritization of which measures to mandate. "Policymakers could require a formal post hoc review evaluating the risks, benefits and harms of the outcome measures after implementation."
3. Performance measures could link a process of care with adverse outcomes when defining incidence of preventable harm. "When standardized surveillance is too costly or risky, processes of care among those sustaining the outcome could be examined. For example, what percentage of patients who develop a DVT (outcome) received appropriate risk assessment and prophylaxis (process)?"
Pronovost this month was named director of the newly established Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He was simultaneously named Johns Hopkins Medicine’s senior vice president for patient safety and quality.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- CEO Exchange: Preparing for Population Health
- Advocate, NorthShore Deal Would Create 16-Hospital System
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Narrow Networks Cut Costs, Not Quality, Economists Say
- 3 Strategies for Retaining Millennial Employees
- 'Early Offer' Malpractice Programs May Spur Reform
- Power of price: In South FL and the nation, healthcare costs often are shrouded in secrecy
- Two NY hospitals to offer free hip and knee replacement surgeries for qualifying patients in December
- Hospital mergers may lead to higher prices